» Articles » PMID: 35296869

Epicardial Adipose Tissue in Contemporary Cardiology

Overview
Journal Nat Rev Cardiol
Date 2022 Mar 17
PMID 35296869
Authors
Affiliations
Soon will be listed here.
Abstract

Interest in epicardial adipose tissue (EAT) is growing rapidly, and research in this area appeals to a broad, multidisciplinary audience. EAT is unique in its anatomy and unobstructed proximity to the heart and has a transcriptome and secretome very different from that of other fat depots. EAT has physiological and pathological properties that vary depending on its location. It can be highly protective for the adjacent myocardium through dynamic brown fat-like thermogenic function and harmful via paracrine or vasocrine secretion of pro-inflammatory and profibrotic cytokines. EAT is a modifiable risk factor that can be assessed with traditional and novel imaging techniques. Coronary and left atrial EAT are involved in the pathogenesis of coronary artery disease and atrial fibrillation, respectively, and it also contributes to the development and progression of heart failure. In addition, EAT might have a role in coronavirus disease 2019 (COVID-19)-related cardiac syndrome. EAT is a reliable potential therapeutic target for drugs with cardiovascular benefits such as glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter 2 inhibitors. This Review provides a comprehensive and up-to-date overview of the role of EAT in cardiovascular disease and highlights the translational nature of EAT research and its applications in contemporary cardiology.

Citing Articles

The role of estrogen in the sex difference for the risk factors of heart failure with preserved ejection fraction.

Du J, Liu J, Wang X, Wang X, Ma Y, Zhang S Biol Direct. 2025; 20(1):28.

PMID: 40065410 PMC: 11895175. DOI: 10.1186/s13062-025-00618-x.


Advances in Pathophysiological Mechanisms of Degenerative Aortic Valve Disease.

Yu Y, Jiang Q Cardiol Res. 2025; 16(2):86-101.

PMID: 40051666 PMC: 11882237. DOI: 10.14740/cr2012.


Aerobic exercise decreases the number and transcript expression of inflammatory M1 macrophages and CD8+ T cells in the epicardial adipose tissue of female pigs.

Ahmad I, Gupta S, Thomas M, Cai J, Heaps C, Newell-Fugate A bioRxiv. 2025; .

PMID: 39975127 PMC: 11838430. DOI: 10.1101/2025.02.02.635562.


Association of Epicardial Adipose Tissue Changes on Serial Chest CT Scans with Mortality: Insights from the National Lung Screening Trial.

Langenbach I, Hadzic I, Zeleznik R, Langenbach M, Maintz D, Mayrhofer T Radiology. 2025; 314(2):e240473.

PMID: 39964263 PMC: 11868846. DOI: 10.1148/radiol.240473.


Proarrhythmic Lipid Inflammatory Mediators: Mechanisms in Obesity Arrhythmias.

Bahrami P, Aromolaran K, Aromolaran A J Cell Physiol. 2025; 240(2):e70012.

PMID: 39943721 PMC: 11822244. DOI: 10.1002/jcp.70012.


References
1.
Iacobellis G, Assael F, Ribaudo M, Zappaterreno A, Alessi G, Di Mario U . Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res. 2003; 11(2):304-10. DOI: 10.1038/oby.2003.45. View

2.
Iacobellis G, Corradi D, Sharma A . Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med. 2005; 2(10):536-43. DOI: 10.1038/ncpcardio0319. View

3.
McAninch E, Fonseca T, Poggioli R, Panos A, Salerno T, Deng Y . Epicardial adipose tissue has a unique transcriptome modified in severe coronary artery disease. Obesity (Silver Spring). 2015; 23(6):1267-78. PMC: 5003780. DOI: 10.1002/oby.21059. View

4.
Iacobellis G . Local and systemic effects of the multifaceted epicardial adipose tissue depot. Nat Rev Endocrinol. 2015; 11(6):363-71. DOI: 10.1038/nrendo.2015.58. View

5.
Iacobellis G . Epicardial fat: a new cardiovascular therapeutic target. Curr Opin Pharmacol. 2016; 27:13-8. DOI: 10.1016/j.coph.2016.01.004. View